Mumbai: Pharma major Pfizer fears that the pharma industry is expected to face challenges from price controls, ad-hoc regulatory changes and new policies that may impact sustainable growth.
from EenaduIndia | Business https://ift.tt/2PT87xs
from EenaduIndia | Business https://ift.tt/2PT87xs
Price control, ad-hoc regulatory changes may hamper pharma sector growth: Pfizer
![Price control, ad-hoc regulatory changes may hamper pharma sector growth: Pfizer]()
Reviewed by placements page
on
September 02, 2018
Rating:
No comments: